Close Menu

NEW YORK (GenomeWeb News) – Plant genomics company Evogene today announced an extension of its deal with Syngenta aimed at developing soybeans resistant to a plant parasite nematode.

The deal extends an agreement originally forged in 2009 by the two firms to identify genes that provide resistance to soybean cyst nematode, a pest that is responsible for about $100 billion in crop damages annually. In the US, nematode-related losses to soybean growers are estimated to reach $1.3 billion annually, Evogene said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.